Cell & Gene Therapy

Ori IRO Charles River Jason Foster Matt Hewitt
Pharma

Charles River looks to help bring Ori's CGT platform forward

Just a few months after the reveal of its automated cell and gene therapy manufacturing platform, Ori is doubling down with one of its chief allies.
Fraiser Kansteiner Sep 18, 2024 8:01am
photo of a sign labeled closed on a business window

Astellas is closing down a gene therapy plant in California

Sep 4, 2024 12:46pm
layoffs

BioMarin lays off 225 more staffers under new corporate strategy

Aug 29, 2024 4:30am
pharma medicine drug manufacturing

Headhunter lays out leadership goals for CDMO industry

Aug 14, 2024 10:51am
YingHuang

Legend CEO talks BIOSECURE Act, M&A rumor and Carvykti growth

Aug 9, 2024 10:30am
Shanbally

BioMarin downsizes gene therapy efforts to focus on 3 markets

Aug 6, 2024 10:34am
More News

FDA signs off on first engineered cell therapy for a solid tumor

Aug 2, 2024 8:56am

Pfizer lays off 210 in North Carolina after gene therapy flop

Jul 29, 2024 11:47am

Precigen nabs pharma veteran Phil Tennant as commercial chief

Jul 23, 2024 10:07am

FDA proposes cell and gene therapy site tours

Jul 15, 2024 4:37pm